Cerebral mTOR signal and pro-inflammatory cytokines in Alzheimer’s disease rats
As a part of Alzheimer’s disease (AD) development the mammalian target of rapamycin (mTOR) has been reported to play a crucial role in regulating cognition and can be used as a neuronal marker. Neuro-inflammation is also a cause of the pathophysiological process in AD. Thus, we examined the protein...
Guardado en:
Autores principales: | Wang Xu, Li Guang-Jian, Hu Hai-Xia, Ma Chi, Ma Di-Hui, Liu Xiao-Liang, Jiang Xiao-Ming |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
De Gruyter
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7014cd78adb44dbb938e073dc8f38040 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Nanotechnology-Based Targeting of mTOR Signaling in Cancer
por: Yoon MS
Publicado: (2020) -
Blocking mammalian target of rapamycin (mTOR) improves neuropathic pain evoked by spinal cord injury
por: Wang Xiaoping, et al.
Publicado: (2016) -
Rapamycin attenuates PLA2R activation-mediated podocyte apoptosis via the PI3K/AKT/mTOR pathway
por: Terry Ting-Yu Chiou, et al.
Publicado: (2021) -
Suppressor of Cytokine Signaling 2 Regulates Retinal Pigment Epithelium Metabolism by Enhancing Autophagy
por: Xi-Yuan Liu, et al.
Publicado: (2021) -
Dual Targeting by Inhibition of Phosphoinositide-3-Kinase and Mammalian Target of Rapamycin Attenuates the Neuroinflammatory Responses in Murine Hippocampal Cells and Seizures in C57BL/6 Mice
por: Preeti Vyas, et al.
Publicado: (2021)